Challenge to be first in a series to crowdsource Alzheimer’s data for new disease insights .
November 11, 2013 by
November 7, 2013 by
The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.